熊樱, 梁立治, 彭小萍, 魏梅, 沈扬. 影响FIGO Ⅰ_b期宫颈鳞癌预后的因素[J]. 中国肿瘤临床, 2007, 34(17): 1008-1011.
引用本文: 熊樱, 梁立治, 彭小萍, 魏梅, 沈扬. 影响FIGO Ⅰ_b期宫颈鳞癌预后的因素[J]. 中国肿瘤临床, 2007, 34(17): 1008-1011.
Xiong Ying, Liang Lizhi, Peng Xiaoping, Wei Mei, Shen Yang. Prognostic Factors of FIGO Ⅰ b Cervical Squamous Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(17): 1008-1011.
Citation: Xiong Ying, Liang Lizhi, Peng Xiaoping, Wei Mei, Shen Yang. Prognostic Factors of FIGO Ⅰ b Cervical Squamous Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(17): 1008-1011.

影响FIGO Ⅰ_b期宫颈鳞癌预后的因素

Prognostic Factors of FIGO Ⅰ b Cervical Squamous Cell Carcinoma

  • 摘要: 目的 :探讨经根治性手术治疗的FIGOⅠb期宫颈鳞癌患者的预后影响因素。 方法 :对174例经我院治疗的Ⅰb期宫颈鳞癌患者的临床资料进行回顾性分析。 结果 :本组病例总5年无瘤生存率为79.4%,复发率为16.7%。肿瘤>4cm者(60例)和≤4cm(114例)者中分别有75.0%和28.1%接受过术前放疗,差异具有显著性(P<0.001)。肿瘤≤4cm/无术前放疗、肿瘤≤4cm/有术前放疗、肿瘤>4cm/无术前放疗和肿瘤>4cm/有术前放疗各组的5年无瘤生存率分别为80.5%、85.2%、69.3%和77.1%,差异无显著性(P>0.05)。单因素分析显示盆腔淋巴结转移、宫旁切缘阳性和术后辅助治疗方式与5年无瘤生存率(P>0.05)显著相关。多因素分析显示影响预后的独立因素为盆腔淋巴结转移(P=0.004)和宫旁切缘阳性(P=0.040)。高危组(伴盆腔淋巴结转移和/或宫旁切缘阳性)中肿瘤≤4cm和>4cm患者的5年无瘤生存率(57.4%vs44.7%,P=0.575)和复发率(7/18vs6/14,P=0.821)无显著差异。低危组(无伴盆腔淋巴结转移或宫旁切缘阳性)中,肿瘤≤4cm和>4cm患者的5年无瘤生存率(86.5%vs82.9%,P>0.05)与复发率(9/95vs7/47,P>0.05)无显著差异。 结论 :对于以根治性手术为主要治疗手段的FIGOⅠb期宫颈鳞癌,盆腔淋巴结转移和宫旁切缘阳性是影响预后的独立因素,肿瘤大小不能为预后预测提供有价值的信息。

     

    Abstract: Objective :To investigate the factor (s) that can accurately predict the prognosis of FI-GO Ib cervical squamous cell carcinoma treated with radical surgery. Methods :The clinical data of174 cases of FIGO Ib cervical squamous cell carcinoma treated in the Department of Gynecologic On-cology in the Cancer Center of Sun Yat-sen University were analyzed. Results :The overall 5-year dis-ease-free survival rate for all patients was 79.4%, and the recurrence rate was 16.7%. 75.0% patientswith tumors >4cm(60 cases) and 28.1% patients with tumors ≤4cm(114cases) received preoperative ra-diation. There was no significant difference in 5-year disease-free survival rate among cases with tu-mors ≤4cm with no preoperative radiation(80.5%), tumors ≤4 cm with preoperative radiation(85.2%),tumors >4cm with no preoperative radiation (69.3%) and tumors >4cm with preoperative radiation(77.1%)(P>0.05). Univariate analysis showed pelvic node metastasis, positive parametrial surgical mar-gin and postoperative adjuvant therapy were significantly correlated with 5-year disease-free survivalrate (P<0.05). Multivariate analysis revealed that pelvic node metastasis (P=0.004) and positive parame-trial surgical margin (P=0.040) were independent factors that influenced prognosis. In the high riskgroup (patients with pelvic node metastasis and/or positive parametrial surgical margin), there was nosignificant difference in 5-year disease-free survival rate (57.4% vs. 44.7%, P=0.575) or recurrencerate (7/18 vs. 6/14, P=0.821) between those with tumors ≤4cm and those with tumors > 4cm. In thelow risk group (patients without node metastasis or positive parametrial surgical margin), there was a-gain no significant difference in 5-year disease-free survival (86.5% vs. 82.9%, P>0.05) or recurrencerate (9/95 vs. 7/47, P>0.05) between patients with tumors ≤4cm and those with tumors > 4cm. Con-Clusion :For FIGO Ib cervical squamous cell carcinoma treated primarily with radical surgery, pelvicnode metastasis and positive parametrial surgical margin are independent factors that influence progno-sis, while tumor size doesn't provide valuable prognostic information.

     

/

返回文章
返回